SCHEMBL1828600

SCHEMBL1828600

O=C1CCCN1Oc1ccccc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.39
MAPT P10636 2/20 0.39
HSD17B10 Q99714 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
POLB P06746 2/20 0.38
HTT P42858 2/20 0.38
ALOX12 P18054 1/20 0.38
LMNA P02545 2/20 0.37
SMN1; SMN2 Q16637 2/20 0.37
RCE1 Q9Y256 1/20 0.37
ALOX5 P09917 1/20 0.37
CASP1 P29466 1/20 0.36
CYP1A2 P05177 3/20 0.36
CYP2D6 P10635 2/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
CYP3A4 P08684 1/20 0.36
HPGD P15428 1/20 0.36
KDM4E B2RXH2 1/20 0.35
MEN1 O00255 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8473466 0.90 ALOX12 (0.41) ALDH1A1ALOX12SMN1; SMN2MEN1KMT2A
SCHEMBL11841829 0.90 CYP1A2 (0.41) ALDH1A1MAPTL3MBTL1POLBLMNA
SCHEMBL11839130 0.82 ALDH1A1 (0.40) ALDH1A1MAPTHSD17B10L3MBTL1POLB
SCHEMBL6985822 0.77 MAPT (0.49) ALDH1A1MAPTL3MBTL1POLBHTT
SCHEMBL7095762 0.77 CYP1A2 (0.31) ALDH1A1SMN1; SMN2ALOX5CYP1A2KDM4E
SCHEMBL28453752 0.73 LTA4H (0.44) ALDH1A1HSD17B10
SCHEMBL6947156 0.73 CASP1 (0.53) ALDH1A1L3MBTL1CASP1
SCHEMBL29289949 0.72 PARL (0.62) ALDH1A1MAPTL3MBTL1HTTLMNA
Hydrochloric Acid SCHEMBL28458984 0.72 LTA4H (0.42) ALDH1A1MAPTHSD17B10POLBLMNA
SCHEMBL5388860 0.72 NPC1 (0.49) ALDH1A1MAPTL3MBTL1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP claimed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO claimed
CN-117362584-A Urethane (meth) acrylate resin, active energy ray-curable composition, cured product, and laminated film DIC株式会社 2024-01-09 CN disclosed
CN-108137508-B 5-HT2CReceptor agonists and compositions and methods of use 艾尼纳制药公司 2021-08-27 CN disclosed
CN-107873030-B 5-HT2CReceptor agonists and compositions and methods of use 艾尼纳制药公司 2021-03-19 CN disclosed
US-20180340174-A1 METHOD FOR IDENTIFICATION OF MOLECULES WITH DESIRED CHARACTERISTICS NANOCORE APS (DK) 2018-11-29 US disclosed
EP-3218479-A1 METHOD FOR IDENTIFICATION OF MOLECULES WITH DESIRED CHARACTERISTICS Nanocore ApS (DK) 2017-09-20 EP disclosed
WO-2016074683-A1 METHOD FOR IDENTIFICATION OF MOLECULES WITH DESIRED CHARACTERISTICS LUNDORF PEDERSEN MATERIALS APS (DK) 2016-05-19 WO disclosed
US-20110230419-A1 IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2011-09-22 US disclosed
EP-2318363-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS Nuevolution A/S (DK) 2011-05-11 EP disclosed
WO-2009152824-A1 HETEROCYCLIC DERIVATIVES AS IAP BINDING COMPOUNDS NUEVOLUTION A/S (DK) 2009-12-23 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110230419-A1 IAP BINDING COMPOUNDS BIRC5, BIRC7, BIRC3 ALDH1A1 2947/4885MAPT 1455/4885HSD17B10 3957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.